Company: GEHC
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001932393-25-000005
Chunk: 121

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 8
Chunk 121
---
2, 2026750 1,150 Other36 52 Total principal debt issued9,036 9,452 Less: Unamortized debt issuance costs and discounts33 35 Add: Cumulative basis adjustment for fair value hedges(51)25 Total borrowings8,951 9,442 Less: Short-term borrowings(1)1,502 1,006 Long-term borrowings$7,449 $8,436 (1) Short-term borrowings as of December 31, 2024 and 2023 includes $1,500 million and $1,002 million, respectively, related to the current portion of our long-term borrowings, net of unamortized debt issuance costs and discounts.Interest expense associated with long-term debt was $580 million, $616 million, and $54 million for the years ended December 31, 2024, 2023, and 2022, respectively, and is included in Interest and other financial charges – net in the Consolidated and Combined Statements of Income.Scheduled maturities of borrowings, excluding amortization of discounts and debt issuance costs, are as follows.20252026202720282029ThereafterTotal$1,506 $779 $1,751 $— $1,000 $4,000 $9,036 See Note 13, “Financial Instruments and Fair Value Measurements” for further information about borrowings and associated derivatives contracts.LETTERS OF CREDIT, GUARANTEES, AND OTHER COMMITMENTS.As of December 31, 2024 and 2023, the Company had bank guarantees and surety bonds of approximately $784 million and $751 million, respectively, related to certain commercial contracts. Additionally, we have issued approximately $25 million and $39 million of guarantees as of December 31, 2024 and 2023, respectively, primarily related to residual value and credit guarantees on equipment sold to third-party finance companies. Our Consolidated Statements of Financial Position reflect a liability of $3 million and $4 million as of December 31, 2024 and 2023, respectively, related to these guarantees. For credit-related guarantees, we estimate our expected credit losses related to off-balance sheet credit exposure consistent with the method used to estimate the allowance for credit losses on financial assets held at amortized cost. See Note 14, “Commitments, Guarante